groups exist to help improve the self-esteem of affected people. in 2019, a 12-person philadelphia jury awarded $8 billion in punitive damages to plaintiffs tied to the use of risperidone. risperidone is an atypical antipsychotic that was originally approved to treat psychosis, but its use in children, including those with autism, adhd, and schizophrenia diagnoses, has grown over the last two decades. in murray v. janssen pharmaceuticals, murray was a risperidone user who was prescribed the medication at age nine and developed male breasts. a jury decided in murray's favor in november 2015 and awarded him $1.75 million. the $1.75 million jury verdict represented damages for "disfigurement and mental anguish," though it was later reduced to $680,000. in the second portion of the bifurcated trial, the plaintiffs sought to prove that the companies knew and deliberately disregarded evidence that risperidone could lead to gynecomastia in young males, and nonetheless promoted the medication off-label and released the medication into the open market for prescription and use by patients without disclosing the side effects. the jury found for the plaintiffs in the second portion of the trial and awarded $8 billion in punitive damages. the amount was later reduced to $6.8 million by judge kenneth powell jr. etymology the term comes from greek γυνή gyné (stem gynaik-) 'female' and μαστός mastós 'breast'.